With 10% YoY growth, Nestle’s domestic revenues are in line with our expectations. Slightly better GMs & lower staff costs helped and Op Ebitda growth at 16% is ahead. Lower other income, however, resulted in an in-line outcome at the net level. Management is confident of managing disruption arising from the second Covid-19 wave although the bigger concern at the moment is on margins, following a sharp rise in input prices. We retain estimates & our Hold rating.
Double-digit growth: Domestic revenues grew 10% y-o-y, similar to the trend seen in the last two quarters. Overall revenue growth was slightly lower at 9%, as export revenues declined 13% due to lower exports to affiliates. Key brands such as Maggi noodles, KitKat, Nescafe Classic, Maggi sauces, Milkmaid and Maggi Masala-ae-magic grew in double-digits. Unlike other FMCG peers, Nestle performed well even in the March quarter last year and hence Q1CY21 does not have a favourable base.
Out-of-home: Nestle’s out-of-home portfolio recovered further q-o-q but remains impacted by Covid-19 disruptions. No comments made by the management on possible disruption due to the second Covid-19 wave; however, it does note that ‘the organisation has learnt to cope with the operating volatility in the pandemic’. However, local restriction would still impact the demand for OOH products, in our view.
E-commerce: The channel witnessed 66% growth y-o-y in Q1CY21 (after 110% growth in CY20) and now contributes 3.8% to domestic revenues.
Input inflation: Gross margin was a tad better than our estimates, down only 50bps q-o-q and up 240bps y-o-y to 58.4%. Gross profit growth was hence strong at 14%. However, going forward, management has sounded caution on the sharp escalation in prices of key inputs and packaging materials, which may impact GM.
Ebitda marginally above: Staff expenses grew just 3% y-o-y (-9% q-o-q). This was partly offset by 14% growth in other expenses, led by higher A&P spends. Ebitda margin, expanded 170bps y-o-y to 25.8%, the highest level in 12 quarters. As a result, Ebitda growth of 16% was marginally better than our estimates.
EPS in line: PBT grew 14% due to lower other income (-31% y-o-y). Pre-ex earnings grew 13% to Rs 6.0 bn and was in line with our estimates.
Retain Hold: We largely maintain our EPS estimates. We expect limited supply disruptions, at least for now due to localised restrictions, unlike last year, along with the learnings & better preparedness on the part of the industry, incl. Nestle. However, out-of-home demand would likely get impacted, like last year. Inflation in key input prices would be a key monitorable going forward. We retain Hold rating with a PT of Rs 18,000.
Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.
Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.
via India Infoline